Literature DB >> 9485205

Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1

M Grell1, F M Becke, H Wajant, D N Männel, P Scheurich.   

Abstract

Tumor necrosis factor (TNF) mediates its biological effects by binding to two distinct but homologous receptor molecules. The type 1 receptor (TNF-R1) has been shown to be essential and sufficient for most cellular responses to soluble TNF. In contrast, only limited data exist concerning the role of the type 2 receptor (TNF-R2) in TNF responses, both in vitro and in vivo. Here, we demonstrate by the use of thymocytes from TNF-R-deficient mice that the TNF-R2-dependent enhancement of proliferation and secretion of granulocyte-macrophage colony-stimulating factor is in fact mediated by TNF-R2 on its own, independent of co-expression and/or stimulation of TNF-R1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485205     DOI: 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

3.  Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.

Authors:  Claudia Mara Ribeiro; Sayonara Rangel Oliveira; Daniela Frizon Alfieri; Tamires Flauzino; Damacio Ramón Kaimen-Maciel; Andréa Name Colado Simão; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Inflamm Res       Date:  2019-09-26       Impact factor: 4.575

Review 4.  Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.

Authors:  Tomohito Gohda; Yasuhiko Tomino
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection.

Authors:  C Li; J Langhorne
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.

Authors:  Xin Chen; Xueqiang Wu; Qiong Zhou; O M Zack Howard; Mihai G Netea; Joost J Oppenheim
Journal:  J Immunol       Date:  2012-12-31       Impact factor: 5.422

Review 7.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

8.  Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.

Authors:  I Parodis; H Ding; A Zickert; L Arnaud; A Larsson; E Svenungsson; C Mohan; I Gunnarsson
Journal:  Scand J Rheumatol       Date:  2016-12-15       Impact factor: 3.641

9.  Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.

Authors:  Rahul Chavan; Daniela Salvador; Michael P Gustafson; Allan B Dietz; Wendy Nevala; Svetomir N Markovic
Journal:  Cancer Immunol Res       Date:  2013-11-18       Impact factor: 11.151

10.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.